B-rayZ Overview
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.32M
- Investors
-
11
B-rayZ General Information
Description
Developer of artificial intelligence-based medical software designed to support radiologists in clinical decisions and workflow automation. The company connects the radiology modalities along the cancer patient journey, starting from breast cancer diagnostics, enabling radiologists to improve breast cancer detection and reduce healthcare costs.
Contact Information
Website
www.b-rayz.comCorporate Office
- Wagistrasse 21
- Schlieren
- 8952 Zurich
- Switzerland
Corporate Office
- Wagistrasse 21
- Schlieren
- 8952 Zurich
- Switzerland
B-rayZ Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 16-Apr-2025 | $2.32M | Completed | Generating Revenue | ||
| 6. Grant | 01-Nov-2022 | Completed | Product Development | |||
| 5. Early Stage VC (Series A) | 07-Jul-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 31-Mar-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 16-Feb-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Nov-2021 | $163K | Completed | Generating Revenue | ||
| 1. Grant | 05-Feb-2019 | $10.1K | Completed | Generating Revenue |
B-rayZ Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
B-rayZ Patents
B-rayZ Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4338167-A1 | Method for improving the performance of medical image analysis by an artificial intelligence and a related system | Pending | 31-May-2021 | ||
| US-12762698-B2 | Method for improving the performance of medical image analysis by an artificial intelligence and a related system | Active | 31-May-2021 | ||
| US-20240242349-A1 | Method for improving the performance of medical image analysis by an artificial intelligence and a related system | Active | 31-May-2021 | ||
| WO-2022253774-A1 | Method for improving the performance of medical image analysis by an artificial intelligence and a related system | Inactive | 31-May-2021 | G16H50/20 |
B-rayZ Signals
B-rayZ Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innosuisse | Government | Minority | ||
| Affidea | PE-Backed Company | Minority | ||
| Convergence Partners (Switzerland) | Venture Capital | Minority | ||
| Eckenstein-Geigy-Stiftung | Not-For-Profit Venture Capital | Minority | ||
| LifeCare Partners | Venture Capital | Minority |
B-rayZ FAQs
-
Where is B-rayZ headquartered?
B-rayZ is headquartered in Zurich, Switzerland.
-
What is the size of B-rayZ?
B-rayZ has 23 total employees.
-
What industry is B-rayZ in?
B-rayZ’s primary industry is Other Healthcare.
-
Is B-rayZ a private or public company?
B-rayZ is a Private company.
-
What is the current valuation of B-rayZ?
The current valuation of B-rayZ is .
-
What is B-rayZ’s current revenue?
The current revenue for B-rayZ is .
-
How much funding has B-rayZ raised over time?
B-rayZ has raised $6.44M.
-
Who are B-rayZ’s investors?
Innosuisse, Affidea, Convergence Partners (Switzerland), Eckenstein-Geigy-Stiftung, and LifeCare Partners are 5 of 11 investors who have invested in B-rayZ.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process